REPORT OF THE KING INSTITUTE, GUINDY

3

for the Wassermann test and of water samples and secondarily to a very
large increase in the output of cholera vaccine. As usual, this statement
does not include the financial value of the work done by investigation units or of
any researches at the Institute, and so the large increase in the estimated
net profit shows better than in any other way how great was the increase in the
routine work of the Institute.

DISTINGUISHED VISITORS.

      1. Sir John Simon, Chairman, Indian Statutory Commission.
      2. Lord Strathcona, Member, Indian Statutory Commission.
      3. Sir Walter Fletcher, K.B.E., D.Sc., M.D., LL.D., Chairman, Medical Research
Committee.
      4. Lt.-Col. S. R. Christophers, F.R.S., C.I.E., I.M.S., Director, Central Research
Institute, Kasauli.
      5. Lt.-Col. S. P. James, M.D., D.P.H, I.M.S., Ministry of Health, London.
      6. Dr. R. Row, Bombay. Member, Medical Research Committee.
      7. Professor T. Madsen, State Serum Institute, Copenhagan.
      8. Dr. Y. Biraud, Geneva.
      9. Professor K. Shiga, Japan.
      10. Dr. T. D. Herelle.
      11. Dr. Wu Lien Teh, China.
      12. Major J. R. Webb, I.M.S.
      13. Dr. Ch. Winchet, Java.
      14. Dr. A. R. Wellington, Federated Malay States.
      15. Dr. Luang Cheott, Siam.
      16. Dr. Harujiro, Korea.
      17. Dr. C. Prommas, Siam.
      18. Dr. Kooru Morishita, Japan.
      19. Dr. R. Gautier, French Indo-China.
      20. Dr. D. W. Hermony, French Indo-China.
      21. Dr. R. Jakano, Japan.
      22. Dr. R. Tze Chick Chin, China.
      23. Dr. A. H. Baldwin, Australia.
      24. Dr. H. L. Hups, Singapore.
      25. Dr. G. Intengan, Philippine Islands.
      26. Dr. A. M. Ramzy, Egypt.
      27. Dr. C. R. Eshay Philippine Islands.
      28. Dr. S. T. Chellappah, Colombo, Ceylon.
      29. Dr. S. Nishiki, Japan.
      30. Dr. L. G. Jourdran, French Indo-China.
      31. Dr. T. J. Stugher, New Zealand.